Boston Scientific Corporation (BSX)

Market Cap	110.67B -27.5%
Revenue (ttm)	20.07B +19.9%
Net Income	2.90B +56.4%
EPS	1.94 +55.2%
Shares Out	1.48B
PE Ratio	38.44
Forward PE	21.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,591,943
Open	75.46
Previous Close	75.72
Day's Range	74.46 - 75.58
52-Week Range	72.69 - 109.50
Beta	0.66
Analysts	Strong Buy
Price Target	109.15 (+46.35%)
Earnings Date	Feb 4, 2026

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatogra...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 18, 1992
• Employees: 59,000
• Stock Exchange: NYSE
• Ticker Symbol: BSX
• Website: https://www.bostonscientific.com

Financial Performance

In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.

Analyst Summary

According to 20 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price target is $109.15, which is an increase of 46.35% from the latest price.

Price Target

$109.15

(46.35% upside)

Analyst Consensus: Strong Buy